NCT07644910

Brief Summary

This study is a randomized controlled field experiment embedded in the medical institution Early Diagnosis Program in Chile. Participants with two exams pending (a cancer screening test and a chronic disease test for diabetes and dyslipidemia) will be randomly assigned across a 3 × 3 factorial design: three message framing conditions (Basic, Risk/Importance, Peace of Mind) crossed with three exam-type conditions (cancer screening only, chronic disease test only, or both exams). Participants with only a cancer screening pending will be assigned to the 3 framing conditions and be encouraged to get the cancer screening. In both cases, participants are assigned to each experimental arm at twice the rate of an additional arm receiving the standard message currently used by the medical institution. This standard-message arm is included for operational purposes, is not part of the pre-specified analyses, and is thus not described in the "Arms and Intervention" section (or counted for "number of arms").

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
235,000

participants targeted

Target at P75+ for not_applicable

Timeline
6mo left

Started Jun 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Jun 2026Dec 2026

First Submitted

Initial submission to the registry

June 8, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

June 8, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 12, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2026

Last Updated

June 12, 2026

Status Verified

June 1, 2026

Enrollment Period

3 months

First QC Date

June 8, 2026

Last Update Submit

June 8, 2026

Conditions

Keywords

Behavioral sciencerandomized controlled trialWhatsApp patient outreachmessage framinginformation avoidancecancer screeningchronic disease testingpreventive care

Outcome Measures

Primary Outcomes (3)

  • Screening Engagement Response

    Binary indicator of whether the patient clicks "Yes, I want help" or provides an equivalent affirmative response via WhatsApp within 7 days of receiving the message (1), or does not take either action (0). Used to test H1a, H1b, H1c, and H2a.

    7 days after message delivery

  • Cancer Screening Appointment

    Binary indicator of whether the patient schedules the recommended cancer screening exam within 7 days of receiving the message (1) or does not (0). Used to test H2b

    7 days after message delivery

  • Chronic Disease Testing Appointment

    Binary indicator of whether the patient schedules the recommended chronic disease test within 7 days of receiving the message (1) or does not (0). Used to test H2c.

    7 days after message delivery

Secondary Outcomes (6)

  • Screening Appointment Scheduling

    7 days after message delivery

  • Screening Test Completion

    12 weeks after message delivery

  • Any Test Appointment Scheduling

    7 days after message delivery

  • Any Test Completion

    12 weeks after message delivery

  • Cancer Screening Completion

    12 weeks after message delivery

  • +1 more secondary outcomes

Study Arms (9)

Basic/Control × Cancer

ACTIVE COMPARATOR

Basic cancer screening message

Behavioral: Basic cancer screening message

Basic/Control × chronic disease test

ACTIVE COMPARATOR

Basic chronic disease test message

Behavioral: Basic chronic disease test message

Basic/Control × Both

ACTIVE COMPARATOR

Basic combined message

Behavioral: Basic combined message

Risk/Importance × Cancer

EXPERIMENTAL

Risk framing cancer screening message

Behavioral: Risk framing cancer screening message

Risk/Importance × Chronic Disease Test

EXPERIMENTAL

Risk framing chronic disease test message

Behavioral: Risk framing chronic disease test message

Risk/Importance × Both

EXPERIMENTAL

Risk framing combined message

Behavioral: Risk framing combined message

Peace of Mind × Cancer screening

EXPERIMENTAL

Peace of mind framing cancer screening message

Behavioral: Peace of mind framing cancer screening message

Peace of Mind × chronic disease Test

EXPERIMENTAL

Peace of mind framing chronic disease test message

Behavioral: Peace of mind framing chronic disease test message

Peace of Mind × Both

EXPERIMENTAL

Peace of mind framing combined message

Behavioral: Peace of mind framing combined message

Interventions

Patients receive a WhatsApp message naming both the recommended cancer screening and the chronic disease test, and describing them as the tests recommended for their age group.

Basic/Control × Both

Patients receive a WhatsApp message naming both exams and emphasizing that getting the exams done on time will give them peace of mind about their health.

Peace of Mind × Both

Patients receive a WhatsApp message naming the recommended chronic disease test and describing it as the test recommended for their age group.

Basic/Control × chronic disease test

Patients receive a WhatsApp message naming their recommended cancer screening exam and describing it as the test recommended for their age group.

Basic/Control × Cancer

Patients receive a WhatsApp message naming their recommended cancer screening exam and emphasizing that (1) the recommendation is based on health risks common to their age group and (2) early detection can be life-saving

Risk/Importance × Cancer

Patients receive a WhatsApp message naming the recommended chronic disease test and emphasizing that (1) the recommendation is based on health risks common to their age group and (2) early detection can be life-saving.

Risk/Importance × Chronic Disease Test

Patients receive a WhatsApp message naming both exams and emphasizing that (1) the recommendation is based on health risks common to their age group and (2) early detection can be life-saving.

Risk/Importance × Both

Patients receive a WhatsApp message naming their recommended cancer screening exam and emphasizing that getting the exam done on time will give them peace of mind about their health.

Peace of Mind × Cancer screening

Patients receive a WhatsApp message naming the recommended chronic disease and emphasizing that getting the exam done on time will give them peace of mind about their health.

Peace of Mind × chronic disease Test

Eligibility Criteria

Age21 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Participants will be excluded from the analysis if the WhatsApp message was not successfully delivered, as reported by the third-party software used by the medical institution.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Breast NeoplasmsUterine Cervical NeoplasmsColorectal NeoplasmsProstatic NeoplasmsDiabetes MellitusDyslipidemias

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesUterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesGenital Neoplasms, MaleGenital Diseases, MaleProstatic DiseasesMale Urogenital DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesLipid Metabolism Disorders

Central Study Contacts

Daniel Schwartz Associate Professor, Department of Industrial Engineering, Ph.D. Behavioral Decision

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
FACTORIAL
Model Details: Patients with two exams pending (a cancer screening test and a chronic disease test for diabetes and dyslipidemia) will be randomly assigned across a 3 × 3 factorial design: three message framing conditions (Basic, Risk/Importance, Peace of Mind) crossed with three exam-type conditions (cancer screening only, chronic disease test only, or both exams). Participants with only a cancer screening pending will be assigned to the 3 framing conditions and be encouraged to get the cancer screening. In both cases, participants are assigned to each experimental arm at twice the rate of an additional arm receiving the standard message currently used by the medical institution. This standard-message arm is included for operational purposes and is not part of the pre-specified analyses.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Department of Industrial Engineering

Study Record Dates

First Submitted

June 8, 2026

First Posted

June 12, 2026

Study Start

June 8, 2026

Primary Completion (Estimated)

September 8, 2026

Study Completion (Estimated)

December 8, 2026

Last Updated

June 12, 2026

Record last verified: 2026-06